The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Interpreting thresholds for a clinically significant change in health status in asthma and COPD
Open accessAbstract
Health status (or Health-Related Quality of Life) measurement is an established method for assessing the overall efficacy of treatments for asthma and chronic obstructive pulmonary disease (COPD). Such measurements can indicate the potential clinical significance of a treatment's effect. This paper is concerned with methods of estimating the threshold of clinical significance for three widely used health status questionnaires for asthma and COPD: the Asthma Quality of Life Questionnaire, Chronic Respiratory Questionnaire and St George's Respiratory Questionnaire. It discusses the methodology used to obtain such estimates and shows that the estimates appear to be fairly reliable; i.e. for a given questionnaire, similar estimates may be obtained in different studies. These empirically derived thresholds are all mean estimates with confidence intervals around them. The presence of these confidence intervals affects the way in which the thresholds may be used to draw inferences concerning the clinical relevance of clinical trial results. A new system of judging the magnitude of clinically significant results is proposed. Finally, an attempt is made to translate these thresholds into scenarios that illustrate what a clinically significant change with treatment may mean to an individual patient.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“SGRQ total score (minimum clinically important difference of 4 units).17”
From Cognitive behavioral therapy for management of dyspnea: A pilot study (2015) · cites this paper as [17]
In the citing paper
“The minimal clinically important difference accepted for this instrument is 0.5 points (26).”
From Health Coaching and Chronic Obstructive Pulmonary Disease Rehospitalization: A Randomized Study (2016) · cites this paper as [26]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jaeschke, R., Singer, J., & Guyatt, G. H. (1989) · Controlled Clinical Trials · doi:10.1016/0197-2456(89)90005-6 · Cited by 4,982
Jones, P. W., Quirk, F. H., Baveystock, C. M., & Littlejohns, P. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/145.6.1321 · Cited by 3,035
Self-citationBestall, J. C., Paul, E. A., Garrod, R., Garnham, R., Jones, P. W., & Wedzicha, J. A. (1999) · Thorax · doi:10.1136/thx.54.7.581 · Cited by 2,927
Self-citationThe St George's Respiratory Questionnaire
Jones, P., Quirk, F. H., & Baveystock, C. M. (1991) · Respiratory Medicine · doi:10.1016/s0954-6111(06)80166-6 · Cited by 2,729
Self-citationDetermining a minimal important change in a disease-specific quality of life questionnaire
JUNIPER, E. (1994) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)90036-1 · Cited by 1,824
A measure of quality of life for clinical trials in chronic lung disease
Guyatt, G. H., Berman, L. B., Townsend, M., Pugsley, S. O., & Chambers, L. W. (1987) · Thorax · doi:10.1136/thx.42.10.773 · Cited by 1,721
Juniper, E. F., Guyatt, G. H., Epstein, R. S., Ferrie, P. J., Jaeschke, R., & Hiller, T. K. (1992) · Thorax · doi:10.1136/thx.47.2.76 · Cited by 1,235
Redelmeier, D. A., Bayoumi, A. M., Goldstein, R. S., & Guyatt, G. H. (1997) · American journal of respiratory and critical care medicine · doi:10.1164/ajrccm.155.4.9105067 · Cited by 1,029
Griffiths, T., Burr, M., Campbell, I., Lewis-Jenkins, V, Mullins, J., Shiels, K., Turner-Lawlor, P., Payne, N., Newcombe, R., Lonescu, A., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(99)07042-7 · Cited by 952
Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease
Lacasse, Y., Wong, E. Y. L., Guyatt, G. H., King, D., Cook, D. J., & Goldstein, R. S. (1996) · The Lancet · doi:10.1016/s0140-6736(96)04201-8 · Cited by 859
Research works printed but not linked: 1
- 1994, Am Rev Respir Crit Care Med, 149, A211
Cited by
Sorted by citations
Items 201–300 of 585
Chan, A. W. K., Lee, A., Lee, D., Sit, J. W. H., & Chair, S. Y. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/425082 · Cited by 45
Efficacy and safety of formoterol fumarate delivered by nebulization to COPD patients
Gross, N. J., Nelson, H. S., Lapidus, R. J., Dunn, L., Lynn, L., Rinehart, M., & Denis-Mize, K. S. (2007) · Respiratory Medicine · doi:10.1016/j.rmed.2007.10.007 · Cited by 45
Monninkhofe, E., van der Valk, P., Schermer, T. R., van der Palen, J. A. M., van Herwaarden, C., & Zielhuis, G. G. (2004) · Chronic Respiratory Disease · doi:10.1191/1479972304cd005oa · Cited by 45
Jung, K., Friede, T., & Beißbarth, T. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-288 · Cited by 46
Hillerdal, G., Löfdahl, C., Ström, K., Skoogh, B., Jorfeldt, L., Nilsson, F. N., Forslund-Stiby, D., Ranstam, J., & Gyllstedt, E. (2005) · CHEST Journal · doi:10.1378/chest.128.5.3489 · Cited by 45
Ng, L., Chiang, L.-K., Tang, R., Siu, C., Fung, L., Lee, A., & Tam, W. (2014) · European Journal of Integrative Medicine · doi:10.1016/j.eujim.2014.01.007 · Cited by 44
Muñoz, G., Buxó, M., de Gracia, J., Olveira, C., Martínez‐García, M. Á., Girón, R. M., Polverino, E., Fernández, A. Á., Birring, S. S., & Vendrell, M. (2016) · Chronic Respiratory Disease · doi:10.1177/1479972316632005 · Cited by 42
Effect of carbocisteine on patients with COPD: a systematic review and meta-analysis
Zeng, Z., Yang, D., Huang, X., & Xiao, Z. (2017) · International Journal of COPD · doi:10.2147/copd.s140603 · Cited by 42
Predictive factors over time of health-related quality of life in COPD patients
Esteban, C., Aróstegui, I., Arámburu, A., Moraza, J., Najera‐Zuloaga, J., Aburto, M., Aizpiri, S., Chasco, L., & Quintana, J. M. (2020) · Respiratory Research · doi:10.1186/s12931-020-01395-z · Cited by 41
Pulmonary rehabilitation in chronic obstructive pulmonary disease
Derom, E., Marchand, É., & Troosters, T. (2007) · Annales de Réadaptation et de Médecine Physique · doi:10.1016/j.annrmp.2007.04.022 · Cited by 40
Monteagudo, M., Rodríguez-Blanco, T., Parcet, J., Peñalver, N. D., Rubio, C., Ferrer, M., & Miravitlles, M. (2011) · Archivos de Bronconeumología · doi:10.1016/s1579-2129(11)70057-x · Cited by 40
Four weeks’ intensive rehabilitation generates significant health effects in COPD patients
Skumlien, S., Skogedal, E. A., Bjørtuft, Ø., & Ryg, M. S. (2007) · Chronic Respiratory Disease · doi:10.1177/1479972306070374 · Cited by 40
Low intensity, long-term outpatient rehabilitation in COPD: a randomised controlled trial
Baumann, H. J., Kluge, S., Rummel, K., Klose, H. F. E., Hennigs, J. K., Schmoller, T., & Meyer, A. A. (2012) · Respiratory Research · doi:10.1186/1465-9921-13-86 · Cited by 39
Bhatt, S. P., Dransfield, M., Cockcroft, J., Wang‐Jairaj, J., Midwinter, D., Rubin, D. B., Scott-Wilson, C. A., & Crim, C. C. (2017) · International Journal of COPD · doi:10.2147/copd.s117373 · Cited by 39
Lingner, H., Buhr-Schinner, H., Hummel, S., van der Meyden, J., Großhennig, A., Nowik, D., & Schultz, K. (2018) · Respiration · doi:10.1159/000486964 · Cited by 39
Al-Ghimlas, F., & TODD, D. C. (2010) · Respirology · doi:10.1111/j.1440-1843.2010.01770.x · Cited by 38
Rebelo, P., Oliveira, A., Paixão, C., Valente, C., Andrade, L., & Marques, A. (2020) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s219480 · Cited by 37
Pavord, I. D., Menzies-Gow, A. N., Buhl, R., Chanez, P., Dransfield, M. T., Lugogo, N. L., Keene, O. N., Bradford, E., & Yancey, S. W. (2020) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2020.08.039 · Cited by 37
Ingadóttir, T. S., & Jónsdóttir, H. (2010) · Journal of Clinical Nursing · doi:10.1111/j.1365-2702.2010.03303.x · Cited by 37
Efficacy and safety of mepolizumab in Japanese patients with severe eosinophilic asthma
Shimoda, T., Odajima, H., Okamasa, A., Kawase, M., Komatsubara, M., Mayer, B., Yancey, S. W., & Ortega, H. G. (2017) · Allergology International · doi:10.1016/j.alit.2016.11.006 · Cited by 36
Vaidya, T., Beaumont, M., de Bisschop, C., Bazerque, L., Blanc, C. L., Vincent, A., Ouksel, H., & Chambellan, A. (2018) · International Journal of COPD · doi:10.2147/copd.s161342 · Cited by 36
Rebelo, P. F. S., Oliveira, A., Andrade, L., Valente, C., & Marques, A. S. P. D. D. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.02.045 · Cited by 36
Liu, M. C., Chipps, B. E., Muñoz, X., Devouassoux, G., Bergna, M. A., Smith, S. G., Price, R. G., Galkin, D., Azmi, J., Mouneimne, D., et al. (2021) · Respiratory Research · doi:10.1186/s12931-021-01733-9 · Cited by 36
Borge, C. R., Mengshoel, A. M., Omenaas, E. R., Moum, T., Ekman, I., Lein, M. P., Mack, U., & Wahl, A. K. (2014) · Patient Education and Counseling · doi:10.1016/j.pec.2014.10.017 · Cited by 36
Martínez, C. H., Moy, M. L., Nguyen, H. Q., Cohen, M., Kadri, R., Roman, P., Holleman, R. G., Kim, H. M., Goodrich, D. E., Giardino, N. D., et al. (2014) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-14-12 · Cited by 36
Nannini, L. J., Lasserson, T., & Poole, P. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003794 · Cited by 36
Evaluation of self-management interventions for chronic obstructive pulmonary disease
Bentsen, S. B., Langeland, E., & Holm, A. L. (2012) · Journal of Nursing Management · doi:10.1111/j.1365-2834.2012.01469.x · Cited by 35
Carone, M., Antoniu, S. A., Baiardi, P., Digilio, V., Jones, P., Bertolotti, G., & on behalf of the QuESS Group (2015) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2015.1067294 · Cited by 37
Self-citationOga, T., Nishimura, K., Tsukino, M., Hajiro, T., Satô, S., Ikeda, A., Hamada, C., & Mishima, M. (2004) · Quality of Life Research · doi:10.1023/b:qure.0000031345.56580.6a · Cited by 34
Bratås, O., Ga, E., Rannestad, T., & Walstad, R. A. (2010) · Chronic Respiratory Disease · doi:10.1177/1479972310374343 · Cited by 34
Dale, M., McKeough, Z. J., Muñoz, P. A., Corte, P., Bye, P. T. P., & Alison, J. A. (2014) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-14-180 · Cited by 34
Integrating Health Status and Survival Data: The Palliative Effect of Lung Volume Reduction Surgery
Benzo, R., Farrell, M. H., Chang, C.-C. H., Martínez, F. J., Kaplan, R. M., Reilly, J. J., Criner, G. J., Wise, R. A., Make, B. J., Luketich, J. D., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200809-1383oc · Cited by 34
Lacasse, Y., Bernard, S., Sériès, F., Nguyen, V. H., Bourbeau, J., Aaron, S. D., & Maltais, F. (2017) · BMC Pulmonary Medicine · doi:10.1186/s12890-016-0343-9 · Cited by 34
Metformin use and respiratory outcomes in asthma-COPD overlap
Wu, T. D., Fawzy, A., Kinney, G. L., Bon, J. M., Neupane, M., Tejwani, V., Hansel, N. N., Wise, R. A., Putcha, N., & McCormack, M. C. (2021) · Respiratory Research · doi:10.1186/s12931-021-01658-3 · Cited by 34
Mölken, M. R., van Nooten, F. E., Lindemann, M., Caeser, M., & Calverley, P. M. A. (2007) · PharmacoEconomics · doi:10.2165/00019053-200725080-00007 · Cited by 33
Ingadottir, A. R., Beck, A. M., Baldwin, C., Weekes, C. E., Geirsdottir, O. G., Ramel, A., Gislason, T., & Gunnarsdottir, I. (2019) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2018-000349 · Cited by 33
Hanania, N. A., Boota, A. M., Kerwin, E., Tomlinson, L., & Denis-Mize, K. S. (2009) · Drugs · doi:10.2165/00003495-200969090-00005 · Cited by 33
Medición de la calidad de vida: ¿cuestionarios genéricos o específicos?
Sanjuás, C. (2005) · Archivos de Bronconeumología · doi:10.1157/13071579 · Cited by 33
Pulmonary rehabilitation: analysis of a clinical service
Garrod, R., Ford, K., Daly, C., Hoareau, C., Howard, M., & Simmonds, C. (2004) · Physiotherapy Research International · doi:10.1002/pri.311 · Cited by 33
Álvarez‐Mon, M., Miravitlles, M., Morera, J., Callol, L., & Álvarez-Sala, J. L. (2005) · CHEST Journal · doi:10.1016/s0012-3692(15)34469-x · Cited by 33
Andenæs, R., Moum, T., Kalfoss, M. H., & Wahl, A. K. (2006) · Quality of Life Research · doi:10.1007/s11136-005-0890-7 · Cited by 32
Outcome of pulmonary rehabilitation in COPD patients with severely impaired health status
van Ranst, D., Otten, Meijer, & Hul, A. J. V. ‘. (2011) · International Journal of COPD · doi:10.2147/copd.s24579 · Cited by 33
Pulmonary Rehabilitation for Moderate COPD (GOLD 2) –Does it Have an Effect?
Gottlieb, V., Lyngsø, A. M., Nybo, B., Frølich, A., & Backer, V. (2011) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2011.610393 · Cited by 32
The St George’s Respiratory Questionnaire revisited: a psychometric evaluation
Paap, M. C. S., Brouwer, D., Glas, C. A. W., Monninkhof, E. M., Forstreuter, B., Pieterse, M. E., & van der Palen, J. A. M. (2013) · Quality of Life Research · doi:10.1007/s11136-013-0570-y · Cited by 32
Trappenburg, J. C. A., Koevoets, L., Oene, G. H. D. W.-V., Monninkhof, E. M., Bourbeau, J., Troosters, T., Verheij, T. J., Lammers, J. J., & Schrijvers, G. (2009) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-9-52 · Cited by 31
Methodological issues in evaluating measures of health as outcomes for COPD
Jones, P. M., & Kaplan, R. M. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00077803 · Cited by 30
Self-citationHealth-Care–Associated Pneumonia
Hiramatsu, K., & Niederman, M. S. (2005) · CHEST Journal · doi:10.1378/chest.128.6.3784 · Cited by 31
Popov, T. A., Петрова, Д., Kralimarkova, T. Z., Ivanov, Y., Popova, T., Peneva, M., Odzhakova, T., Ilieva, Y., Yakovliev, P., Lazarova, T., et al. (2013) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2013.06.002 · Cited by 30
Hypogammaglobulinemia and Risk of Exacerbation and Mortality in Patients with COPD
Holm, A. M., Andreassen, S. L., Christensen, V. L., Kongerud, J. S., Almås, Ø., Auråen, H., Henriksen, A. H., Aaberge, I. S., Klingenberg, O., & Rustøen, T. (2020) · International Journal of COPD · doi:10.2147/copd.s236656 · Cited by 30
Drugs (including oxygen) in severe COPD
Albert, P., & Calverley, P. (2008) · European Respiratory Journal · doi:10.1183/09031936.00116707 · Cited by 29
Clinically meaningful outcomes in patients with chronic obstructive pulmonary disease
ZuWallack, R., Haggerty, M. C., & Jones, P. W. (2004) · The American Journal of Medicine Supplements · doi:10.1016/j.amjmed.2004.10.020 · Cited by 30
Self-citationLiu, F., Tang, Zou, Wang, Xu, Wei, Wang, Cui, & Cai (2013) · Patient Preference and Adherence · doi:10.2147/ppa.s43305 · Cited by 29
Fukuchi, Y., Samoro, R., Fassakhov, R. S., Taniguchi, H., Ekelund, J., Carlsson, L., & Ichinose, M. (2013) · Respirology · doi:10.1111/resp.12090 · Cited by 29
Tsai, C., & Camargo, C. A. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2008.10.005 · Cited by 29
Haemoglobin as a biomarker for clinical outcomes in chronic obstructive pulmonary disease
Balasubramanian, A., Henderson, R. J., Putcha, N., Fawzy, A., Raju, S., Hansel, N. N., MacIntyre, N. R., Jensen, R. L., Kinney, G. L., Stringer, W. W., et al. (2021) · ERJ Open Research · doi:10.1183/23120541.00068-2021 · Cited by 29
Descriptive analysis of the respiratory health status of persons exposed to Libby amphibole asbestos
Winters, C. A., Hill, W. G., Rowse, K., Black, B., Kuntz, S. W., & Weinert, C. (2012) · BMJ Open · doi:10.1136/bmjopen-2012-001552 · Cited by 29
Qualitative evaluation of the St George's Respiratory Questionnaire in patients with severe asthma
Nelsen, L. M., Kimel, M., Murray, L. T., Ortega, H. G., Cockle, S. M., Yancey, S. W., Brusselle, G., Albers, F. C., & Jones, P. (2017) · Respiratory Medicine · doi:10.1016/j.rmed.2017.02.021 · Cited by 29
Self-citationAugustin, I. M. L., Wouters, E. F. �., Houben‐Wilke, S., Gaffron, S., Janssen, D. J. A., Franssen, F. M. E., & Spruit, M. A. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm8010027 · Cited by 29
Puhan, M., Schunemann, H., Frey, M., & Bachmann, L. (2004) · Respiratory Research · doi:10.1186/1465-9921-5-25 · Cited by 32
Matheson, A. M., McIntosh, M. J., Kooner, H. K., Abdelrazek, M., Albert, M. S., Dhaliwal, I., Nicholson, J. M., Ouriadov, A. V., Svenningsen, S., & Párraga, G. (2023) · Thorax · doi:10.1136/thorax-2022-219378 · Cited by 28
Pinnock, H., Hanley, J., Lewis, S. C., MacNee, W., Pagliari, C., Pol, M. M. V. D., Sheikhg, A., & McKinstry, B. (2009) · Primary Care Respiratory Journal · doi:10.4104/pcrj.2009.00040 · Cited by 28
How important is a minimal difference?
Troosters, T. (2011) · European Respiratory Journal · doi:10.1183/09031936.00156410 · Cited by 28
Biological effects of p38 MAPK inhibitor losmapimod does not translate to clinical benefits in COPD
Pascoe, S. J., Costa, M. J., Marks-Kończalik, J., McKie, E., Yang, S., & Scherbovsky, P. S. (2017) · Respiratory Medicine · doi:10.1016/j.rmed.2017.07.002 · Cited by 27
Duenk, R. G., Heijdra, Y. F., Verhagen, S. C. A. H. H. V. M., Dekhuijzen, R. P. N., Vissers, K. C. P., & Engels, Y. (2014) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-14-54 · Cited by 27
Interpreting patient-reported outcomes from clinical trials in COPD: a discussion
Jones, P., Rennard, S. I., Tabberer, M. M., Riley, J., Vahdati-Bolouri, M., & Barnes, N. C. (2016) · International Journal of COPD · doi:10.2147/copd.s117378 · Cited by 27
Self-citationŽupanič, E., Živanović, I., Kališnik, J. M., Avbelj, V., & Lainščak, M. (2014) · European Respiratory Journal · doi:10.1183/13993003/erj.44.suppl_58.p3038 · Cited by 27
Giorgio, A. D., Dante, A., Cavioni, V., Padovan, A. M., Rigonat, D., Iseppi, F., Graceffa, G., & Gulotta, F. (2017) · Frontiers in Psychology · doi:10.3389/fpsyg.2017.01682 · Cited by 27
Rehman, A. U., Hassali, M. A., Harun, S. N., Abbas, S., Muneswarao, J., Ali, I. A. H., & Hussain, R. (2020) · Health and Quality of Life Outcomes · doi:10.1186/s12955-020-01393-1 · Cited by 28
Distinct symptom experiences in subgroups of patients with COPD
Holm, A. M., Christensen, V. L., Rustøen, T., Cooper, B., Miaskowski, C. A., Henriksen, A. H., & Bentsen, S. B. (2016) · International Journal of COPD · doi:10.2147/copd.s105299 · Cited by 27
Wood-Baker, R. R., Walters, J. A., & Walters, E. H. (2006) · Respiratory Medicine · doi:10.1016/j.rmed.2006.07.013 · Cited by 26
Airway inflammation contributes to health status in COPD: a cross-sectional study
Snoeck-Stroband, J. B., Postma, D. S., Lapperre, T. S., Gosman, M. M. E., Thiadens, H. A., Kauffman, H. F., Sont, J. K., Jansen, D. F., & Sterk, P. J. (2006) · Respiratory Research · doi:10.1186/1465-9921-7-140 · Cited by 27
Cordova‐Rivera, L., Gibson, P. G., Gardiner, P. A., Hiles, S. A., & McDonald, V. M. (2019) · Respiratory Medicine · doi:10.1016/j.rmed.2019.06.010 · Cited by 25
von Spee-Mayer, C., Echternach, C., Agarwal, P., Gutenberger, S., Soetedjo, V., Goldacker, S., & Warnatz, K. (2020) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2020.10.028 · Cited by 25
Bové, D. G., Overgaard, D., Lomborg, K. E., Lindhardt, B. Ø., & Midtgaard, J. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-008031 · Cited by 25
Obaseki, D., Erhabor, G., Awopeju, O., Obaseki, J., & Adewole, O. (2013) · African Health Sciences · doi:10.4314/ahs.v13i3.25 · Cited by 25
Patients’ preferences shed light on the murky world of guideline‐based medicine
Penston, J. G. (2007) · Journal of Evaluation in Clinical Practice · doi:10.1111/j.1365-2753.2006.00701.x · Cited by 24
Holm, K. E., Soo Borson, B., Sandhaus, R. A., Ford, D. W., Strange, C., Bowler, R. P., Make, B. J., & Wamboldt, F. S. (2013) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2012.719049 · Cited by 25
Haughney, J., & Gruffydd‐Jones, K. (2004) · Primary Care Respiratory Journal · doi:10.1016/j.pcrj.2004.06.006 · Cited by 25
Omalizumab (Xolair®) improves quality of life in adult patients with allergic asthma: a review
Buhl, R. (2003) · Respiratory Medicine · doi:10.1053/rmed.2003.1442 · Cited by 25
Eberhardt, R., Herth, F. J. F., Radhakrishnan, S., & Gompelmann, D. (2015) · Respiration · doi:10.1159/000437358 · Cited by 24
Tessarin, G., Baronio, M., Gazzurelli, L., Rossi, S., Chiarini, M., Moratto, D., Giliani, S. C., Bondioni, M. P., Badolato, R., & Lougaris, V. (2023) · Journal of Clinical Immunology · doi:10.1007/s10875-023-01587-4 · Cited by 24
Valero, C., Monteagudo, M., Llagostera, M., Huguet, X. B., Granollers, S., Acedo, M., Ferro, J. J., Rodríguez-Latre, L., Almeda, J., & Muñoz, L. (2009) · BMC Public Health · doi:10.1186/1471-2458-9-442 · Cited by 24
Quality of life, stage severity and COPD
Jenkins, C., & Rodriguez‐Roisin, R. (2009) · European Respiratory Journal · doi:10.1183/09031936.00019009 · Cited by 24
Effect of tiotropium on quality of life in COPD: a systematic review
Kaplan, A. G. (2010) · Primary Care Respiratory Journal · doi:10.4104/pcrj.2010.00067 · Cited by 24
Wang, L., He, L., Tao, Y., Sun, L. N., Zheng, H., Zheng, Y., Shen, Y., Liu, S., Zhao, Y., & Wang, Y. (2017) · Journal of Medical Internet Research · doi:10.2196/jmir.6743 · Cited by 24
MacNab, M., Lee, S. H., McCloughan, L., Hanley, J., McKinstry, B., & Pinnock, H. (2015) · BMC Health Services Research · doi:10.1186/s12913-015-1135-2 · Cited by 21
Taylor, S. J., Eldridge, S. M., Chang, Y.-M., Sohanpal, R., & Clarke, A. (2007) · Chronic Respiratory Disease · doi:10.1177/1479972306074478 · Cited by 23
Kanao, K., Shiraishi, M., Higashimoto, Y., Maeda, K., Sugiya, R., OKAJIMA, S., Chiba, Y., Yamagata, T., Terada, K., Fukuda, K., et al. (2015) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.12656 · Cited by 23
Bellocq, A., Gaspard, W., Couffignal, C., Vigan, M., Guerder, A., Ambard, J., Caruana, S., Similowski, T., Garcia, G., & Taillé, C. (2019) · Journal of Asthma · doi:10.1080/02770903.2018.1541351 · Cited by 23
Twiss, J., Doward, L. C., McKenna, S. P., & Eckert, B. J. (2010) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-8-117 · Cited by 23
Rodríguez‐Góncer, I., Harris, C., Kosmidis, C., Muldoon, E. G., Newton, P. J., & Denning, D. W. (2018) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2018.06.001 · Cited by 23
Mepolizumab for COPD with Eosinophilic Phenotype following Hospitalization
Flynn, C. A., McAuley, H. J. C., Elneima, O., Aung, H., Ibrahim, W., Ward, T., Bourne, M., Thornton, T. D., Mistry, V., Gilbert, H. R., et al. (2025) · NEJM Evidence · doi:10.1056/evidoa2500012 · Cited by 22
Efficacy of indacaterol in the treatment of patients with COPD
Jones, P., Barnes, N. C., Vogelmeier, C. F., Lawrence, D., & Krämer, B. (2011) · Primary Care Respiratory Journal · doi:10.4104/pcrj.2011.00066 · Cited by 22
Self-citationLee, S. H., Lee, H., Kim, Y. S., Park, H., Lee, M. K., & Kim, K. U. (2019) · The Clinical Respiratory Journal · doi:10.1111/crj.13104 · Cited by 22
Wootton, S. L., McKeough, Z. J., Ng, L. W. C., JENKINS, S. C., Hill, K., Eastwood, P. R., Hillman, D. R., Jenkins, C. R., Cecins, N. M., Spencer, L., et al. (2017) · Respirology · doi:10.1111/resp.13128 · Cited by 22
Dourado, V. Z., Antunes, L. C. D. O., Tanni, S. É., & Godoy, I. (2009) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37132009000900005 · Cited by 22
Hiles, S. A., Guerrero, P. D. U., Gibson, P. G., Bogdanovs, A., & McDonald, V. M. (2021) · BMC Pulmonary Medicine · doi:10.1186/s12890-021-01436-3 · Cited by 23
Triple Therapy for the Management of COPD: A Review
Gaebel, K., McIvor, A., Xie, F., Blackhouse, G., Robertson, D., Assasi, N., Hernandez, P., & Goeree, R. A. (2011) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2011.560131 · Cited by 21
Hindelang, M., Kirsch, F. W., & Leidl, R. (2020) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2020.1734455 · Cited by 21
Monitoring the quality-of-life in allergic disorders
Leynaert, B., & Soussan, D. (2003) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/00130832-200306000-00005 · Cited by 21
Metadata
- Authors
- Jones, P. W.
- Affiliations
- St George's, University of London (GB)
- Corresponding author
- Jones, P.W.
- ORCID
- Jones, P.W.
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2002-03
- Volume
- 19
- Issue
- 3
- Pages
- 398-404
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W2141887601
- Cited by
- 585
- References
- 22
- Citations by year
- 2026: 12 · 2025: 8 · 2024: 5 · 2023: 11 · 2022: 17 · 2021: 26 · 2020: 40 · 2019: 30 · 2018: 21 · 2017: 33 · 2016: 22 · 2015: 32 · 2014: 40 · 2013: 37 · 2012: 22
- FWCI
- 22.66
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- European Respiratory Journal (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Keywords
- clinically significant change, health-related quality of life, asthma, chronic obstructive pulmonary disease, Asthma Quality of Life Questionnaire, Chronic Respiratory Questionnaire, St George's Respiratory Questionnaire, confidence intervals
- MeSH terms
- Asthma, Female, Health Status, Health Status Indicators, Humans, Male, Prognosis, Quality of Life, Surveys and Questionnaires, Respiratory Function Tests, Sensitivity and Specificity, Severity of Illness Index, Reproducibility of Results, Confidence Intervals, Treatment Outcome, Patient Satisfaction, Pulmonary Disease, Chronic Obstructive
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review